American Society of Clinical Oncology
The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Drs. Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, ASCO has nearly 45,000 members worldwide.
|Motto||Making a world of difference in cancer care|
ASCO offers several educational resources for cancer physicians and other health care professionals in the field of clinical oncology. These resources include scientific meetings, educational conferences, professional workshops, and special symposia on issues of particular relevance and importance to oncologists and researchers.
ASCO publishes numerous journals, books, newsletters, and online and multimedia resources. In addition to producing the patient information website, Cancer.Net, ASCO publishes the Journal of Clinical Oncology (JCO), the Journal of Oncology Practice (JOP), and the Journal of Global Oncology (JGO). Two other online-only journals published by ASCO include JCO Clinical Cancer Informatics, which publishes clinically relevant research based on biomedical informatics methods and processes applied to cancer-related data, information, and images, and JCO Precision Oncology, which publishes original research, reports, opinions, and reviews related to precision oncology and genomics-driven care of patients with cancer.
ASCO also publishes special curricula to address specific educational needs of cancer professionals.
With over 40,000 attendees the ASCO Annual Meeting is one of the largest educational and scientific events in the oncology community. The five-day event provides a venue for physicians and scientists to present research results to a global audience of oncology professionals.
- Journal of Clinical Oncology
- Journal of Oncology Practice
- Journal of Global Oncology
- JCO Clinical Cancer Informatics
- JCO Precision Oncology
- ASCO Connection
Created by members of ASCO, the Conquer Cancer Foundation of ASCO is a 501(c)(3) charitable organization seeking dramatic advances in the prevention, treatment, and cures of all types of cancer. Since the inception of its grants and awards program in 1984, Conquer Cancer has awarded more than $90 million in funding through nearly 1,500 grants and awards to researchers in 65 countries. In 2015, the foundation launched The Campaign to Conquer Cancer, a comprehensive campaign to raise $150 million to fund cancer research, support Conquer Cancer's top priorities, and bring national awareness to the Foundation.
ASCO's patient information website, Cancer.Net, is supported by the Conquer Cancer Foundation of ASCO, and provides information relevant for people with cancer.
CancerLinQ is ASCO's data platform initiative. It was created to give oncologists a robust quality monitoring system that collects and analyzes data from all patient encounters so they can deliver patients the highest possible quality of care.
ASCO published its Value Framework in 2015  and updated it in 2016 . The ASCO Value Framework provides physicians and patients with a tool to assess and compare the value of different drugs in an era of skyrocking anticancer drug costs.
- "About JCO". Journal of Clinical Oncology. Retrieved 16 December 2015.
- "About JOP". Journal of Oncology Practice. Retrieved 16 December 2015.
- "General Information". Journal of Global Oncology.
- "JCO Clinical Cancer Informatics". American Society of Clinical Oncology.
- "JCO Precision Oncology". American Society of Clinical Oncology.
- "Call for Abstracts". 2012 ASCO Annual Meeting. Retrieved 16 December 2015.
- Schnipper LE, Davidson NE, Wollins DS, Tyne C, Blayney DW, Blum D, et al. (August 2015). "American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options". Journal of Clinical Oncology. 33 (23): 2563–77. doi:10.1200/JCO.2015.61.6706. PMC 5015427. PMID 26101248.
- Schnipper LE, Davidson NE, Wollins DS, Blayney DW, Dicker AP, Ganz PA, et al. (August 2016). "Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received". Journal of Clinical Oncology. 34 (24): 2925–34. doi:10.1200/JCO.2016.68.2518. PMID 27247218.
- Røe OD (September 2017). "The High Cost of New Cancer Therapies-A Challenge of Inequality for All Countries". JAMA Oncology. 3 (9): 1169–1170. doi:10.1001/jamaoncol.2016.6335. PMID 28033441.